Driehaus Capital Management LLC Purchases Shares of 1,152 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Driehaus Capital Management LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,152 shares of the medical equipment provider's stock, valued at approximately $601,000.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after acquiring an additional 243,802 shares during the period. Fisher Asset Management LLC lifted its position in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the period. Norges Bank acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $2,401,493,000. Finally, Invesco Ltd. lifted its position in shares of Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after acquiring an additional 295,025 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 2,401 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the sale, the executive vice president now directly owns 353 shares of the company's stock, valued at approximately $205,093. This trade represents a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,680 shares of company stock worth $16,854,345 over the last ninety days. Corporate insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Citigroup upped their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Royal Bank of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Trading Up 0.4%

ISRG traded up $1.99 during trading on Wednesday, hitting $565.94. The stock had a trading volume of 1,409,652 shares, compared to its average volume of 1,637,122. The company has a 50 day simple moving average of $501.31 and a 200-day simple moving average of $535.58. Intuitive Surgical, Inc. has a 12 month low of $386.00 and a 12 month high of $616.00. The firm has a market cap of $202.84 billion, a PE ratio of 88.29, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.